These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33134121)

  • 41. Pulmonary Tuberculosis and Rifampicin Resistant Mycobacterium Tuberculosis in Children and Adolescents using Gene Xpert MTB/RIF Assay in Tigray, Northern Ethiopia.
    Dejene TA; Hailu GG; Kahsay AG; Wasihun AG
    Infect Drug Resist; 2023; 16():6757-6765. PubMed ID: 37876859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021.
    Biset S; Teferi M; Alamirew H; Birhanu B; Dessie A; Aschale A; Haymanot A; Dejenie S; Gebremedhin T; Abebe W; Adane G
    BMC Infect Dis; 2024 Feb; 24(1):238. PubMed ID: 38389060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV-burden setting.
    Matabane MM; Ismail F; Strydom KA; Onwuegbuna O; Omar SV; Ismail N
    BMC Infect Dis; 2015 Nov; 15():508. PubMed ID: 26553046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF.
    Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA
    J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015-2019.
    Wasihun AG; Hailu GG; Dejene TA
    Infect Dis Ther; 2021 Sep; 10(3):1299-1308. PubMed ID: 33950463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia.
    Admassu W; Ayelign B; Abebe G; Tadesse M
    PLoS One; 2022; 17(1):e0262929. PubMed ID: 35085337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance and impact of GeneXpert MTB/RIF® and Loopamp MTBC Detection Kit® assays on tuberculosis case detection in Madagascar.
    Rakotosamimanana N; Lapierre SG; Raharimanga V; Raherison MS; Knoblauch AM; Raherinandrasana AH; Rakotoson A; Rakotonirina J; Rasolofo V
    BMC Infect Dis; 2019 Jun; 19(1):542. PubMed ID: 31221109
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
    Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
    BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urine Xpert MTB/RIF for the diagnosis of childhood tuberculosis.
    Lopez AL; Aldaba JG; Morales-Dizon M; Sarol JN; Daag JV; Ama MC; Sylim P; Salonga A; Nielsen-Saines K
    Int J Infect Dis; 2019 Feb; 79():44-46. PubMed ID: 30496848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Performance of Line Probe Assay (Version 2) and Xpert MTB/RIF Assay for Early Diagnosis of Rifampicin-Resistant Pulmonary Tuberculosis.
    Yadav RN; Kumar Singh B; Sharma R; Chaubey J; Sinha S; Jorwal P
    Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):237-244. PubMed ID: 33657709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis.
    Subbaraman R; Nathavitharana RR; Satyanarayana S; Pai M; Thomas BE; Chadha VK; Rade K; Swaminathan S; Mayer KH
    PLoS Med; 2016 Oct; 13(10):e1002149. PubMed ID: 27780217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.
    Raizada N; Sachdeva KS; Sreenivas A; Vadera B; Gupta RS; Parmar M; Kulsange S; Babre A; Thakur R; Gray C; Ramachandran R; Alavadi U; Ghedia M; Vollepore B; Dewan P; Boehme C; Paramsivan CN
    PLoS One; 2014; 9(2):e89301. PubMed ID: 24586675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019.
    Basawarajappa SG; Rangaiah A; Padukone S; Yadav PD; Gupta N; Shankar SM
    Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):144-150. PubMed ID: 33818471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.
    Horne DJ; Kohli M; Zifodya JS; Schiller I; Dendukuri N; Tollefson D; Schumacher SG; Ochodo EA; Pai M; Steingart KR
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD009593. PubMed ID: 31173647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
    Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
    PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The value of Xpert MTB/RIF assay of urine samples in the early diagnosis of smear-negative urinary tuberculosis.
    Wang Y; Tan J; Lei L; Yuan Y; Li W; Zhao Y; Wang Y; Niu X; Li Z; Wei L; Han Y; Cheng M; Guo X; Han X; Wang W
    Eur J Med Res; 2022 Dec; 27(1):300. PubMed ID: 36539899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.
    Kohli M; Schiller I; Dendukuri N; Yao M; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012768. PubMed ID: 33448348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.